S. Venuraju, A. Jeevarethinam, V. Mehta, M. Cohen, D. A. Darko, D. Nair, R. Rakhit, J. Nilsson, A. Lahiri
{"title":"肥胖2型糖尿病患者严重冠状动脉粥样硬化发生率降低-肥胖悖论?","authors":"S. Venuraju, A. Jeevarethinam, V. Mehta, M. Cohen, D. A. Darko, D. Nair, R. Rakhit, J. Nilsson, A. Lahiri","doi":"10.52964/ijcd.0009","DOIUrl":null,"url":null,"abstract":"An obesity paradox wherein a lower incidence of cardiovascular (CV) morbidity and mortality is seen in overweight/ obese patients compared with patients with a ‘normal’ body mass index (BMI) has been reported in patients with type 2 diabetes mellitus (T2DM). We evaluated the relationship between BMI and coronary atherosclerosis in a cohort of subjects with T2DM who were asymptomatic for CV disease using computed tomography coronary angiography. Subjects were followed up for a composite endpoint of all-cause death, non-fatal myocardial infarction or late coronary artery revascularisation. Of the 258 patients enrolled, 226 were eligible for follow-up over a median of 22.8 months. In patients with a normal BMI (<25 kg/m2), 53% had ≥1 significantly stenotic plaque compared with 26% of patients with a BMI >30 kg/m2 at baseline. Subjects with a BMI ≥35 kg/m2 were 82% less likely to present with significant coronary artery plaque at baseline compared with those with a BMI <25 kg/m2 (p=0.01). The risk of a composite CV endpoint event in the overweight/obese group (>25 kg/m2) was approximately 70% lower than in subjects with normal weight. In conclusion, higher BMI may be associated with a lower prevalence of coronary atherosclerosis in patients with T2DM.","PeriodicalId":348058,"journal":{"name":"The International Journal of cardiodiabetes","volume":"55 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reduced Incidence of Severe Coronary Atherosclerosis in Obese Subjects With Type 2 Diabetes – An Obesity Paradox?\",\"authors\":\"S. Venuraju, A. Jeevarethinam, V. Mehta, M. Cohen, D. A. Darko, D. Nair, R. Rakhit, J. Nilsson, A. Lahiri\",\"doi\":\"10.52964/ijcd.0009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"An obesity paradox wherein a lower incidence of cardiovascular (CV) morbidity and mortality is seen in overweight/ obese patients compared with patients with a ‘normal’ body mass index (BMI) has been reported in patients with type 2 diabetes mellitus (T2DM). We evaluated the relationship between BMI and coronary atherosclerosis in a cohort of subjects with T2DM who were asymptomatic for CV disease using computed tomography coronary angiography. Subjects were followed up for a composite endpoint of all-cause death, non-fatal myocardial infarction or late coronary artery revascularisation. Of the 258 patients enrolled, 226 were eligible for follow-up over a median of 22.8 months. In patients with a normal BMI (<25 kg/m2), 53% had ≥1 significantly stenotic plaque compared with 26% of patients with a BMI >30 kg/m2 at baseline. Subjects with a BMI ≥35 kg/m2 were 82% less likely to present with significant coronary artery plaque at baseline compared with those with a BMI <25 kg/m2 (p=0.01). The risk of a composite CV endpoint event in the overweight/obese group (>25 kg/m2) was approximately 70% lower than in subjects with normal weight. In conclusion, higher BMI may be associated with a lower prevalence of coronary atherosclerosis in patients with T2DM.\",\"PeriodicalId\":348058,\"journal\":{\"name\":\"The International Journal of cardiodiabetes\",\"volume\":\"55 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The International Journal of cardiodiabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52964/ijcd.0009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The International Journal of cardiodiabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52964/ijcd.0009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Reduced Incidence of Severe Coronary Atherosclerosis in Obese Subjects With Type 2 Diabetes – An Obesity Paradox?
An obesity paradox wherein a lower incidence of cardiovascular (CV) morbidity and mortality is seen in overweight/ obese patients compared with patients with a ‘normal’ body mass index (BMI) has been reported in patients with type 2 diabetes mellitus (T2DM). We evaluated the relationship between BMI and coronary atherosclerosis in a cohort of subjects with T2DM who were asymptomatic for CV disease using computed tomography coronary angiography. Subjects were followed up for a composite endpoint of all-cause death, non-fatal myocardial infarction or late coronary artery revascularisation. Of the 258 patients enrolled, 226 were eligible for follow-up over a median of 22.8 months. In patients with a normal BMI (<25 kg/m2), 53% had ≥1 significantly stenotic plaque compared with 26% of patients with a BMI >30 kg/m2 at baseline. Subjects with a BMI ≥35 kg/m2 were 82% less likely to present with significant coronary artery plaque at baseline compared with those with a BMI <25 kg/m2 (p=0.01). The risk of a composite CV endpoint event in the overweight/obese group (>25 kg/m2) was approximately 70% lower than in subjects with normal weight. In conclusion, higher BMI may be associated with a lower prevalence of coronary atherosclerosis in patients with T2DM.